Is Nexeon MedSystems Inc. a good investment? Nexeon MedSystems Inc. (NXNN) is currently trading at 0.000100 USD.
No, it does not currently pay a dividend.
Nexeon MedSystems Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
| Split Date | Split Ratio to 1 |
|---|---|
| June 28, 2018 | 0.070000 |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion